Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CALTX.ST Stock Summary
Top 10 Correlated ETFs
CALTX.ST
In the News
CALTX.ST Financial details
Company Rating
Buy
Market Cap
6.05B
Income
-466.18M
Revenue
1.21B
Book val./share
6.24
Cash/share
18.14
Dividend
-
Dividend %
-
Employees
192
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-24.8
Forward P/E
4.72
PEG
-21.44
P/S
5.41
P/B
19.22
P/C
6.25
P/FCF
-56.32
Quick Ratio
2.96
Current Ratio
3.01
Debt / Equity
2.81
LT Debt / Equity
2.81
-
-
EPS (TTM)
-8.68
EPS next Y
24.01
EPS next Q
-0.95
EPS this Y
11.7%
EPS next Y
-376.65%
EPS next 5Y
-926.01%
EPS last 5Y
58.09%
Revenue last 5Y
45.54%
Revenue Q/Q
53.28%
EPS Q/Q
-89.17%
-
-
-
-
SMA20
3.67%
SMA50
-11.02%
SMA100
24.18%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-47%
ROC
-0.22%
Gross Margin
97%
Oper. Margin
-23%
Profit Margin
-22%
Payout
-
Shs Outstand
53.67M
Shs Float
37.9M
-
-
-
-
Target Price
-
52W Range
80.8-141.9
52W High
-19.57%
52W Low
+41.75%
RSI
53
Rel Volume
0.19
Avg Volume
274.65K
Volume
52.48K
Perf Week
1.16%
Perf Month
5.1%
Perf Quarter
14.89%
Perf Half Y
9.25%
-
-
-
-
Beta
1.393
-
-
Volatility
1.64%, 3.22%
Prev Close
-1.22%
Price
113.4
Change
-1.48%
CALTX.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5 | 0.02 | 4.51 | 15.15 | 22.49 | |
Net income per share | -0.88 | -9.73 | -10.02 | -7.78 | -8.69 | |
Operating cash flow per share | -1.92 | -6.89 | -9.08 | -5.88 | -8.1 | |
Free cash flow per share | -2.36 | -6.89 | -9.53 | -5.92 | -8.1 | |
Cash per share | 20.4 | 22.2 | 18.8 | 23.57 | 18.14 | |
Book value per share | 21.33 | 26.98 | 19.84 | 14.46 | 6.24 | |
Tangible book value per share | 20.9 | 17.71 | 11.98 | 5.33 | 6.24 | |
Share holders equity per share | 21.33 | 26.98 | 19.84 | 14.46 | 6.24 | |
Interest debt per share | 0.17 | 0.12 | 5.32 | 14.19 | 19.07 | |
Market cap | 2.8B | 6.26B | 5.73B | 4.9B | 6.82B | |
Enterprise value | 2.05B | 5.27B | 4.99B | 4.38B | 6.81B | |
P/E ratio | -85.84 | -14.35 | -11.25 | -11.88 | -14.63 | |
Price to sales ratio | 15.13 | 7.17K | 25 | 6.1 | 5.65 | |
POCF ratio | -39.38 | -20.26 | -12.42 | -15.73 | -15.69 | |
PFCF ratio | -32.07 | -20.26 | -11.84 | -15.61 | -15.69 | |
P/B Ratio | 3.55 | 5.18 | 5.69 | 6.39 | 20.38 | |
PTB ratio | 3.55 | 5.18 | 5.69 | 6.39 | 20.38 | |
EV to sales | 11.09 | 6.03K | 21.76 | 5.45 | 5.65 | |
Enterprise value over EBITDA | -81.53 | -13.92 | -9.52 | -10.38 | -16.36 | |
EV to operating cash flow | -28.85 | -17.05 | -10.81 | -14.06 | -15.68 | |
EV to free cash flow | -23.5 | -17.05 | -10.31 | -13.95 | -15.68 | |
Earnings yield | -0.01 | -0.07 | -0.09 | -0.08 | -0.07 | |
Free cash flow yield | -0.03 | -0.05 | -0.08 | -0.06 | -0.06 | |
Debt to equity | 0.01 | 0 | 0.26 | 0.96 | 2.81 | |
Debt to assets | 0.01 | 0 | 0.18 | 0.38 | 0.51 | |
Net debt to EBITDA | 29.74 | 2.62 | 1.42 | 1.23 | 0.02 | |
Current ratio | 15.39 | 9.82 | 7.48 | 4.34 | 3.13 | |
Interest coverage | -86.21 | -966.21 | -73.78 | -33.69 | -4.96 | |
Income quality | 2.53 | 0.81 | 0.88 | 0.74 | 0.93 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.34 | 117.57 | 0.92 | 0.32 | 0 | |
Research and developement to revenue | 0.81 | 276.17 | 1.56 | 0.52 | 0.42 | |
Intangibles to total assets | 0.02 | 0.31 | 0.27 | 0.25 | 0 | |
Capex to operating cash flow | 0.23 | 0 | 0.05 | 0.01 | 0 | |
Capex to revenue | -0.09 | 0 | -0.1 | 0 | 0 | |
Capex to depreciation | -8.88 | 0 | -0.66 | -0.19 | 0 | |
Stock based compensation to revenue | 0 | 6.88 | 0.1 | 0.04 | 0 | |
Graham number | 20.57 | 76.84 | 66.89 | 50.31 | 34.92 | |
ROIC | -0.04 | -0.31 | -0.4 | -0.28 | -0.33 | |
Return on tangible assets | -0.04 | -0.42 | -0.48 | -0.28 | -0.25 | |
Graham Net | 20.05 | 16.92 | 10.75 | 3.47 | -7.32 | |
Working capital | 767.76M | 931.23M | 877.33M | 1.09B | 868.01M | |
Tangible asset value | 772.01M | 794.93M | 608.86M | 282.42M | 334.81M | |
Net current asset value | 764M | 786.7M | 561.14M | 225.49M | -249.29M | |
Invested capital | 0.01 | 0 | 0.26 | 0.96 | 2.81 | |
Average receivables | 23.29M | 32.17M | 37.06M | 107.92M | 178.06M | |
Average payables | 23.51M | 39.11M | 60.9M | 114.19M | 130.48M | |
Average inventory | 9.34M | 9.34M | 444.5K | 2.27M | 12.04M | |
Days sales outstanding | 92 | 7.41K | 89.72 | 72.49 | 59.48 | |
Days payables outstanding | 0 | 0 | 0 | 3.85K | 607.08 | |
Days of inventory on hand | 0 | 0 | 0 | 87.57 | 123.32 | |
Receivables turnover | 3.97 | 0.05 | 4.07 | 5.03 | 6.14 | |
Payables turnover | 0 | 0 | 0 | 0.09 | 0.6 | |
Inventory turnover | 0 | 0 | 0 | 4.17 | 2.96 | |
ROE | -0.04 | -0.36 | -0.51 | -0.54 | -1.39 | |
Capex per share | -0.44 | 0 | -0.45 | -0.05 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.31 | 3.57 | 5.02 | 5.49 | 8.41 | |
Net income per share | -0.07 | -3.49 | -1.71 | -3.14 | -0.34 | |
Operating cash flow per share | 4.46 | -4.32 | -3.04 | -1.17 | 0.43 | |
Free cash flow per share | 4.41 | -4.32 | -3.04 | -1.17 | 0.43 | |
Cash per share | 24.19 | 18.89 | 16.14 | 14.66 | 18.14 | |
Book value per share | 14.84 | 10.98 | 9.4 | 6.57 | 6.24 | |
Tangible book value per share | 5.47 | 1.94 | -0.2 | -2.31 | 6.24 | |
Share holders equity per share | 14.84 | 10.98 | 9.4 | 6.57 | 6.24 | |
Interest debt per share | 13.88 | 14.01 | 14.52 | 14.43 | 18.55 | |
Market cap | 4.77B | 6.73B | 4.65B | 5.23B | 6.82B | |
Enterprise value | 4.25B | 6.46B | 4.57B | 5.22B | 6.81B | |
P/E ratio | -324.19 | -8.97 | -12.65 | -7.77 | -92.85 | |
Price to sales ratio | 11.13 | 35.15 | 17.27 | 17.76 | 15.11 | |
POCF ratio | 20.75 | -29 | -28.54 | -83.69 | 298.61 | |
PFCF ratio | 20.98 | -29 | -28.54 | -83.69 | 298.61 | |
P/B Ratio | 6.23 | 11.41 | 9.23 | 14.85 | 20.38 | |
PTB ratio | 6.23 | 11.41 | 9.23 | 14.85 | 20.38 | |
EV to sales | 9.91 | 33.75 | 16.95 | 17.71 | 15.09 | |
Enterprise value over EBITDA | 130.89 | -36.36 | -60.75 | -32.69 | 231.64 | |
EV to operating cash flow | 18.49 | -27.85 | -28.01 | -83.42 | 298.3 | |
EV to free cash flow | 18.69 | -27.85 | -28.01 | -83.42 | 298.3 | |
Earnings yield | 0 | -0.03 | -0.02 | -0.03 | 0 | |
Free cash flow yield | 0.05 | -0.03 | -0.04 | -0.01 | 0 | |
Debt to equity | 0.96 | 1.23 | 1.55 | 2.19 | 2.81 | |
Debt to assets | 0.38 | 0.4 | 0.46 | 0.48 | 0.51 | |
Net debt to EBITDA | -16.01 | 1.5 | 1.15 | 0.1 | -0.24 | |
Current ratio | 4.34 | 3.93 | 3.84 | 3.01 | 3.13 | |
Interest coverage | 0.55 | -6.59 | 0 | -35.39 | 0.53 | |
Income quality | 7.08 | 1.24 | 2.17 | 0.39 | -1.24 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.19 | 0.38 | 0.29 | 0.3 | 0 | |
Research and developement to revenue | 0.24 | 0.66 | 0.33 | 0.61 | 0.24 | |
Intangibles to total assets | 0.25 | 0.27 | 0.3 | 0.3 | 0 | |
Capex to operating cash flow | -0.01 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.01 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.19 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.08 | 0 | 0 | 0 | 0 | |
Graham number | 4.88 | 29.38 | 19.03 | 21.53 | 6.93 | |
ROIC | 0 | -0.12 | -0.07 | -0.14 | 0.03 | |
Return on tangible assets | 0 | -0.14 | -0.08 | -0.15 | -0.01 | |
Graham Net | 3.56 | -1.82 | -2.93 | -5.4 | -7.32 | |
Working capital | 1.09B | 909.63M | 823.28M | 691.3M | 868.01M | |
Tangible asset value | 282.42M | 104.31M | -10.66M | -124.08M | 334.81M | |
Net current asset value | 225.49M | 20.39M | -91.19M | -223.44M | -249.29M | |
Invested capital | 0.96 | 1.23 | 1.55 | 2.19 | 2.81 | |
Average receivables | 173.32M | 134.51M | 169.63M | 231.42M | 214.9M | |
Average payables | 128.08M | 134.2M | 90.02M | 69.6M | 83.86M | |
Average inventory | 2.11M | 7.9M | 14.93M | 16.85M | 18.22M | |
Days sales outstanding | 33.45 | 51.53 | 76.74 | 71.22 | 39.2 | |
Days payables outstanding | 1.83K | 1.08K | 456.12 | 405.12 | 405.88 | |
Days of inventory on hand | 41.66 | 121.22 | 112.05 | 96.54 | 82.45 | |
Receivables turnover | 2.69 | 1.75 | 1.17 | 1.26 | 2.3 | |
Payables turnover | 0.05 | 0.08 | 0.2 | 0.22 | 0.22 | |
Inventory turnover | 2.16 | 0.74 | 0.8 | 0.93 | 1.09 | |
ROE | 0 | -0.32 | -0.18 | -0.48 | -0.05 | |
Capex per share | -0.05 | 0 | 0 | 0 | 0 |
CALTX.ST Frequently Asked Questions
What is Calliditas Therapeutics AB (publ) stock symbol ?
Calliditas Therapeutics AB (publ) is a SE stock and trading under the symbol CALTX.ST
What is Calliditas Therapeutics AB (publ) stock quote today ?
Calliditas Therapeutics AB (publ) stock price is $113.4 today.
Is Calliditas Therapeutics AB (publ) stock public?
Yes, Calliditas Therapeutics AB (publ) is a publicly traded company.